EFMC-ISMC 2012

22nd International Symposium on Medicinal Chemistry

 Berlin, Germany    September 2-6, 2012

Committees


International Organising Committee

Symposium Chairmen

B. CLEMENT

University of Kiel, Kiel, Germany

E. OTTOW

Bayer HealthCare, Berlin, Germany

Members

K. AUGUSTYNS

University of Antwerp, Antwerp, Belgium

R. P. CLAUSEN

University of Copenhagen, Copenhagen, Denmark

E. DIFFERDING

Differding Consulting, Louvain-la-Neuve, Belgium

R. MOREIRA

University of Lisbon, Lisbon, Portugal

H. TIMMERMAN

VU University Amsterdam, Oegstgeest, The Netherlands

Local Organising Committee

Members

K.-H. ALTMANN

ETH Zurich, Zurich, Switzerland

A. BUSCHAUER

University of Regensburg, Regensburg, Germany

P. GMEINER

Friedrich Alexander University, Erlangen, Germany

R. HAAG

Free University Berlin, Berlin, Germany

M. KALESSE

University of Hannover, Hannover, Germany

S. LAUFER

University of Tübingen, Tübingen, Germany

J. MACK

Boehringer Ingelheim, Biberach an der Riss, Germany

H. P. MAERKI

F. Hoffmann-La Roche, Basel, Switzerland

P. H. SEEBERGER

Max Planck Institute of Colloids and Interfaces, Berlin, Germany

O. SEITZ

Humboldt University Berlin, Berlin, Germany

H. U. STILZ

Novo Nordisk, Malov, Denmark

R. D. SÜSSMUTH

Technical University Berlin, Berlin, Germany

H. WALDMANN

Max Planck Institute of Molecular Physiology, Dortmund, Germany

H. WEINMANN

Bayer Pharma, Berlin, Germany

International Scientific Committee

Members

M. D. ANDREWS

Pfizer, Sandwich, United Kingdom

P. ARTURSON

University of Uppsala, Uppsala, Sweden

S. O. BACHURIN

Institute of Physiologically Active Compounds, Chernogolovka, Russia

E. BANOGLU

Gazi University, Ankara, Turkey

M. BRANDS

Bayer Pharma AG, Wuppertal, Germany

T. CARELL

Ludwig-Maximilians-University Munich, Munich, Germany

N. CARRUTHERS

Johnson & Johnson R&D, San Diego, United States

G. CRISTALLI

University of Camerino, Camerino, Italy

F. DA SETTIMO

Università di Pisa, Pisa, Italy

P. S. DA SILVA

Bial Ltd, S. Mamede do Coronado, Portugal

A. M. DAVIS

AstraZeneca R&D, Loughborough, United Kingdom

F. DENONNE

UCB Pharma, Braine-l'Alleud, Belgium

G. DUBURS

Latvian Institute of Organic synthesis, Riga, Latvia

G. ECKER

University of Vienna, Vienna, Austria

P. ETTMAYER

Boehringer Ingelheim, Vienna, Austria

J. FISCHER

Richter Plc, Budapest, Hungary

C. GARCIA-ECHEVERRIA

Sanofi, Vitry sur Seine, France

M. GASIC

Serbian Academy of Sciences and Art, Belgrade, Serbia

G. GAVIRAGHI

Siena Biotech, Siena, Italy

E. GILLAM

University Queensland, Brisbane, Australia

M. HANN

GSK Medicines Research Centre, Stevenage, United Kingdom

R. HARTMANN

Saarland University, Saarbrücken, Germany

L. HENNEQUIN

AstraZeneca, Reims, France

T. HOFFMANN

F. Hoffmann-La Roche, Basel, Switzerland

U. HOLZGRABE

University of Wuerzburg, Wuerzburg, Germany

K. KIEC-KONONOWICZ

Jagiellonian University, Krakow, Poland

G. KLEBE

Philipps-University Marburg, Marburg, Germany

A. KOUROUNAKIS

University of Athens, Athens, Greece

J. LAU

Novo Nordisk, Maaloev, Denmark

B. LESUR

Institut de Recherches Servier, Croissy-Sur-Seine, France

R. LEURS

VU University Amsterdam, Amsterdam, The Netherlands

M. L. LOPEZ-RODRIGUEZ

Complutense University of Madrid, Madrid, Spain

D. MA

Shanghai Institute of Organic Chemistry, Shanghai, China

I. MALNAR

Halmed, Zagreb, Croatia

R. MECHOULAM

Hebrew University, Jerusalem, Israel

L. MEERPOEL

Janssen R&D, Beerse, Belgium

R. METTERNICH

F. Hoffmann-La Roche, Basel, Switzerland

J. MINERS

Flinders University School of Medicine, Bedford Park, Australia

M. MISSBACH

Novartis, Basel, Switzerland

C. MÜLLER

University of Bonn, Bonn, Germany

K. MÜLLER

F. Hoffmann-La Roche, Switzerland

P. O'NEILL

University of Liverpool, Liverpool, United Kingdom

D. OLIVER

North-West University, Potchefstroom, South Africa

R. PELLICCIARI

University of Perugia, Corciano, Italy

L. PETERLIN MASIC

University of Ljubljana, Ljubljana, Slovenia

D. ROGNAN

CNRS/UNIVERSITY OF STRASBOURG, Illkirch, France

Y. ROLLAND

Société de Chimie Thérapeutique, Châtenay-Malabry, France

M. ROWLEY

Merck Research Laboratories, Kriens, Switzerland

F. SANZ

University Pompeu Fabra, Barcelona, Spain

G. SCHNEIDER

ETH Zürich, Zurich, Switzerland

G. SERRA

Udelar, Montevideo, Uruguay

K. B. SIMONSEN

Lundbeck, Valby, Denmark

G. TAMAGNAN

Institute for Neurodegenerative Disorders and Molecular NeuroImaging, LLC, New Haven, United States

B. K. TRIVEDI

Wockhardt R&D, Aurangabad, India

J. UETRECHT

University of Toronto, Toronto, Canada

E. WALLEN

University of Helsinki, Helsinki, Finland

H. WEINSTEIN

Cornell University, New York, United States

R. WEXLER

Bristol-Myers Squibb, Princeton, United States

J. WÖLFLING

University of Szeged, Szeged, Hungary

A. YONATH

Weizmann Institute of Science, Rehovot, Israel

L.-H. ZHANG

Beying Medical University, Beying, China

M.-Q. ZHANG

Amgen China, Shanghai, China